Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT02771626 · TERMINATED
Trial details
- NCT number
- NCT02771626
- Sponsor
- Calithera Biosciences, Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-04-24
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.